SANUWAVE Health, Inc.
$19.94
▲
0.3%
2026-04-21 09:32:00
sanuwave.com
NGM: SNWV
Explore SANUWAVE Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$177.13 M
Current Price
$19.94
52W High / Low
$46.59 / $16.27
Stock P/E
14.99
Book Value
$0.19
Dividend Yield
—
ROCE
25.36%
ROE
-166.66%
Face Value
—
EPS
$0.41
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
55
Beta
1.51
Debt / Equity
1,418.84
Current Ratio
1.38
Quick Ratio
1.05
Forward P/E
-1,684
Price / Sales
3.29
Enterprise Value
$155.74 M
EV / EBITDA
20.8
EV / Revenue
3.54
Rating
None
Target Price
$43.5
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Return on equity is on the weaker side.
- Leverage is relatively high.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 2. | Beyond Air, Inc. | $0.55 | — | $6.22 M | — | -177.71% | -2.4% | $5.84 / $0.43 | $0.96 |
| 3. | Axogen, Inc. | $37.23 | — | $2 B | — | -3.96% | -13.49% | $39.99 / $9.22 | $2.73 |
| 4. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 5. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 6. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 7. | Establishment Labs Holdings Inc. | $66.93 | — | $1.96 B | — | -14.18% | -1.33% | $83.31 / $28.67 | $0.8 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 13.09 M | 11.45 M | 10.16 M | 9.34 M | 10.33 M | — |
| Operating Profit | 0.61 M | 1.47 M | 1.88 M | 0.99 M | 2.52 M | — |
| Net Profit | 6.11 M | 10.32 M | 1.05 M | -5.68 M | -12.75 M | — |
| EPS in Rs | 0.71 | 1.2 | 0.12 | -0.66 | -1.48 | -6.49 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 44.05 M | 32.63 M | 20.4 M | 16.74 M |
| Operating Profit | 4.95 M | 3.85 M | -0.54 M | -8.95 M |
| Net Profit | 11.81 M | -33.08 M | -25.81 M | -10.29 M |
| EPS in Rs | 1.37 | -3.85 | -3 | -1.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 37.34 M | 30.12 M | 22.42 M | 19.87 M |
| Total Liabilities | 35.72 M | 45.91 M | 65.59 M | 60.88 M |
| Equity | 1.62 M | -15.79 M | -43.18 M | -41.01 M |
| Current Assets | 24.63 M | 18.4 M | 9.78 M | 6.62 M |
| Current Liabilities | 17.85 M | 45.42 M | 64.75 M | 60.22 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.88 M | 2.46 M | -4.54 M | -17.17 M |
| Investing CF | 3.43 M | -0.49 M | 0.02 M | 0.33 M |
| Financing CF | -5.59 M | 6.35 M | 5.21 M | 17.38 M |
| Free CF | 1.93 M | 1.97 M | -4.54 M | -17.17 M |
| Capex | -1.94 M | -0.49 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 59.99% | 21.84% | — | — |
| Earnings Growth % | -28.19% | -150.72% | — | — |
| Profit Margin % | -101.38% | -126.52% | -61.48% | — |
| Operating Margin % | 11.79% | -2.65% | -53.47% | — |
| Gross Margin % | 75.23% | 70.41% | 74.13% | — |
| EBITDA Margin % | -55.56% | -44.87% | 28.63% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.